Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.43 |
| ▸ | NPY1R | P25929 | 9/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.43 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.37 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.37 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658141 | 0.94 | NPY4R (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30685283 | 0.91 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30658148 | 0.91 | ENPEP (0.42) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL32679342 | 0.91 | NPY4R (0.40) | NPY4RNPY1RNPY5RNPY2RSIRT2 | |
| SCHEMBL29540572 | 0.91 | NPY4R (0.39) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31265325 | 0.89 | NPY4R (0.43) | NPY4RNPY1RNPY5RNPY2RSIRT5 | |
| SCHEMBL29697049 | 0.89 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL9819648 | 0.89 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL9819642 | 0.89 | NPY4R (0.41) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29784994 | 0.87 | NPY4R (0.45) | NPY4RNPY1RNPY5RNPY2RPDCD1LG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-02-10 | — | — | US | claimed |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2025-09-09 | — | — | US | claimed |
| CN-118979012-A | Thawing liquid for ovum or embryo and preparation method and thawing method thereof | 上海北里永幸医疗器械有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-111793110-B | Application of DMSO-free cryopreservation liquid in stem cell cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-11-11 | — | — | CN | claimed |
| CN-111789100-B | Application of DMSO-free cryopreservation solution in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | claimed |
| CN-111789099-B | Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos | 北京大学第三医院 | 2022-09-06 | — | — | CN | claimed |
| CN-111789102-B | Application of thawing solution in thawing frozen and preserved oocyte or embryo | 北京大学第三医院 | 2022-07-12 | — | — | CN | claimed |
| US-20220192180-A1 | THAWING FLUID, PREPARATION METHOD THEREFOR AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-23 | — | — | US | claimed |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2022-06-02 | — | — | US | claimed |
| CN-111793108-B | Application of cryopreservation liquid containing peptide compounds in organ and tissue cryopreservation | 北京大学第三医院（北京大学第三临床医学院） | 2022-05-27 | — | — | CN | claimed |
| CN-111793109-B | Peptide compound and cryopreservation liquid containing same | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| CN-111789103-B | Thawing solution for cryopreservation and thawing method | 中国科学院化学研究所 | 2022-05-27 | — | — | CN | claimed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | claimed |
| CN-111793107-B | DMSO-free cryopreservation liquid and preparation method thereof | 中国科学院化学研究所 | 2022-04-12 | — | — | CN | claimed |
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2026-02-10 | — | — | US | disclosed |
| US-12453345-B2 | Serum-free cryopreservation solution and preparation method and application thereof | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2025-10-28 | — | — | US | disclosed |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | PEKING UNIVERSITY THIRD HOSPITAL (CN) | 2025-09-09 | — | — | US | disclosed |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | INSTITUTE OF CHEMISTRY, CHINESE ACADEMIC OF SCIENCES (CN) | 2022-05-12 | — | — | US | disclosed |
| CN-111793107-B | DMSO-free cryopreservation liquid and preparation method thereof | 中国科学院化学研究所 | 2022-04-12 | — | — | CN | disclosed |
| CN-111790327-B | Molecular design method of ice control material | 中国科学院化学研究所 | 2022-03-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12543727-B2 | Thawing fluid, preparation method therefor and use thereof | PCMT1, ARGLU1, TTR | NPY4R 3235/4885NPY1R 2711/4885NPY5R 3579/4885 |
| US-20220142148-A1 | SERUM-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND APPLICATION THEREOF | BCL2L1, BCL2, BCL2L11 | NPY4R 4591/4885NPY1R 4003/4885NPY5R 4470/4885 |
| US-12408659-B2 | DMSO-free cryopreservation solution and preparation method and use thereof | BCL2, BCL2L1, BCL2L2 | NPY4R 4809/4885NPY1R 4266/4885NPY5R 4740/4885 |
| US-12453345-B2 | Serum-free cryopreservation solution and preparation method and application thereof | BCL2L1, BCL2, BCL2L11 | NPY4R 4591/4885NPY1R 4003/4885NPY5R 4470/4885 |
| US-20220167610-A1 | DMSO-FREE CRYOPRESERVATION SOLUTION AND PREPARATION METHOD AND USE THEREOF | BCL2, BCL2L1, BCL2L2 | NPY4R 4809/4885NPY1R 4266/4885NPY5R 4740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.